contact us

Disease-Focused AI Modules

Modular Clinical Analytics in Development

LATAMED AI is developing disease-focused artificial intelligence modules designed to operate within its broader AI healthcare analytics architecture. Each module is structured to support predictive modeling, structured clinical insight generation, and workflow optimization within specific specialty domains.

All modules remain in development. The Company has not obtained regulatory clearance for diagnostic claims and has not completed clinical validation studies.

CardioAI™

Cardiovascular Risk & Imaging Analytics (In Development)

CardioAI is being developed to support cardiovascular-focused predictive modeling and structured clinical analytics by integrating multidimensional data.

Proposed Capabilities Under Development
Heart failure risk modeling
Arrhythmia detection algorithms
Coronary artery disease scoring
AI-assisted ECG analysis
Structured cardiovascular risk stratification outputs
The module is designed to integrate clinical parameters, physiological indicators, and imaging data inputs to generate structured decision-support outputs for professional review. CardioAI is intended to function as a clinical support tool and is not designed to replace licensed medical judgment.
Cardiology Analysis

PulmoAI™

Pulmonary Risk & Respiratory Analytics (In Development)

PulmoAI focuses on respiratory health, using AI to analyze lung function data and imaging to predict chronic pulmonary conditions earlier.

Proposed Capabilities Under Development
Lung capacity trend analysis
COPD progression modeling
Pneumonia detection support
Respiratory sound classification
Automated pulmonary function test interpretation
Designed to streamline respiratory clinical workflows, PulmoAI assists clinicians in monitoring patient lung health through structured analytics.
Pulmonary Analysis

NeuroAI™

Neurological Imaging & Cognitive Analytics (In Development)

NeuroAI leverages advanced neural networks to identify patterns in neurological imaging and signal data for cognitive health monitoring.

Proposed Capabilities Under Development
Stroke risk factor mapping
Early cognitive decline tracking
Brain volume change analytics
EEG signal pattern recognition
Neurological pathway visualization support
NeuroAI aims to provide insights into complex neurological data, supporting specialists in long-term patient cognitive management.
Neurological Analysis

Modular & Expandable Framework

Each disease-focused module is designed to operate within the LATAMED AI Engine™ architecture while leveraging
disease-specific modeling parameters and analytical configurations. The modular framework is intended to support
future specialty expansion into additional clinical domains as development progresses.

All modules remain in development. The Company has not obtained regulatory clearance for diagnostic claims and has not completed clinical validation studies.

Ready to Transform Healthcare Delivery?

Discover how LATAMED AI’s intelligent healthcare infrastructure can support your organization’s strategic objectives.
Explore Platform
Building intelligent healthcare infrastructure for emerging markets through AI-enabled analytics and coordinated care systems.

Platform

Company

Investor Relations

LATAMED AI is a brand name used by Catalyst Crew Technologies Corp. Catalyst Crew Technologies Corp. is a publicly traded company subject to the reporting requirements of the Securities Exchange Act of 1934.